Jefferson University Hospitals

Brain Tumor Center

Related Content
Brain Tumor Center

The Jefferson Brain Tumor Center of the Sidney Kimmel Cancer Center and the Vickie and Jack Farber Institute for Neuroscience provides a multidisciplinary approach to treating brain tumors, giving patients access to care all in one place and during one visit. Combining expertise in Radiation Oncology, Neurosurgery, Neuro-Oncology and Medical Oncology, our Center physicians provide exceptional care and access to the latest protocols for patients coping with this life-threatening diagnosis.

Advantages of Choosing Jefferson

Our Brain Tumor Center distinguishes itself in many ways:

  • The volume of patients we have treated (more than 3,000)
  • Our team of experts performs more than 600 surgeries annually, making Jefferson one of the busiest brain tumor practices in the tri-state area.
  • Our surgical approaches and radiosurgery techniques yield an overall volume that is unrivaled in the tri-state area.
  • We have the largest number of neurosurgeons, neuro-oncologists and radiation oncologists dedicated to treating brain tumors of any center within a 100-mile radius.

The Sidney Kimmel Cancer Center at Jefferson, a National Cancer Institute (NCI)-designated clinical cancer center, and the Vickie and Jack Farber Institute for Neuroscience treats more patients with malignant and benign brain tumors than all other area university-based hospital programs combined. Our specialists create a seamless and carefully coordinated treatment plan for a patient in just a few minutes. This is important because a delay in treatment diminishes success for patients.

Stereotactic Radiosurgery Treatment

Our team has 20+ years of experience treating more than 5,000 benign and malignant brain tumors. We are pioneers in the development of fractionated stereotactic radiotherapy with the first installation worldwide of a LINAC designed for and dedicated to radiosurgery.

Using leading-edge noninvasive techniques, our radiosurgery platforms allow us to treat a number of brain tumors, skull base tumors and facial pain by creating a complex sculpted radiation plan tailored to the individual patient's tumor.

Clinical Trials & Research

At the Jefferson Brain Tumor Center, we offer numerous leading-edge clinical trials for our patients and are involved in ongoing brain tumor research.

There are approximately 17,000 primary brain tumors diagnosed in the United States each year, 60 percent of which are gliomas. Minimizing neurological side effects in patients with high-grade gliomas from chemoradiation may result in improved patient survival, a new study from our radiation oncologists suggests.

It is generally considered that the only way to improve survival in malignant brain tumors is to more effectively attack the tumor. However, our research suggests that damage to surrounding normal tissue may also play a role in determining a patient's long-term outcome.

Other researchers from Jefferson have found that patients who received hypofractionated stereotactic radiotherapy for their recurrent brain cancers lived longer lives.

Not only does hypofractionated stereotactic radiotherapy provide longer survival, patients do not experience side effects commonly seen with use of chemotherapies and targeted therapies. These findings set a new bar for the treatment of recurrent gliomas.

Make an Appointment

Call 1-800-JEFF-NOW (1-800-533-3669) to make an appointment with a Jefferson Health specialist at our Brain Tumor Center.

Center Leadership